SAN FRANCISCO Deal teams from Wilson Sonsini Goodrich & Rosati and Davis Polk & Wardwell are working on a planned IPO for Pacific Biosciences. Wilson Sonsini is advising the company, while Davis Polk represents the underwriters.
Pacific Biosciences, a Menlo Park-based developer of tools for biological research, filed with the Securities and Exchange Commission Monday to raise up to $200 million in its initial public offering. Details, such as the number of shares to be sold or their price range, have not been released. Pacific Biosciences’ machines are used by researchers to study DNA, RNA and proteins. The company said in its filing that it anticipates its technology will be of use in testing for certain medical conditions, as well as in agriculture, food production and the development of biofuels.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
